In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI

Ann Rheum Dis. 2016 Jun;75(6):e34. doi: 10.1136/annrheumdis-2016-209317. Epub 2016 Mar 9.
No abstract available

Keywords: B cells; Sjøgren's Syndrome; Treatment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived
  • B-Lymphocytes
  • Humans
  • Parotid Gland
  • Rituximab*
  • Sjogren's Syndrome*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab